• About us
• Contact

Advertisement

Product › Details

filgotinib (GLPG0634)

	Next higher product group	JAK1 inhibitor
	Status	2020-09-25 registration start
	Organisation	Galapagos N.V. (Euronext + Nasdaq: GLPG)
	Group	Galapagos (Group)

Record changed: 2023-07-10

Advertisement

More documents for filgotinib (GLPG0634)

• [1] Galapagos N.V.. (8/30/21). "Press Release: Galapagos Announces Planned Retirement of CEO". Mechelen....
• [2] Galapagos N.V.. (12/15/20). "Press Release: Gilead and Galapagos Announce New Commercialization and Development Agreement for Jyseleca (filgotinib)". Foster City, CA & Mechelen....
• [3] Galapagos N.V.. (8/19/20). "Press Release: Galapagos Announces that Gilead Received a Complete Response Letter for Filgotinib for the Treatment of Moderately to Severely Active Rheumatoid Arthritis". Mechelen....
• [4] Galapagos N.V.. (1/23/20). "Press Release: Galapagos Appoints Michele Manto as Chief Commercial Officer". Mechelen....
• [5] Galapagos N.V.. (10/10/19). "Press Release: Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis". Foster City, CA & Mechelen....
• [6] Galapagos N.V.. (8/28/19). "Press Release: Transparency Notification – Gilead Holds 22% of Galapagos Shares". Mechelen....
• [7] Galapagos N.V.. (8/23/19). "Press Release: Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration". Foster City, CA & Mechelen....
• [8] Galapagos N.V.. (8/15/19). "Press Release: European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis". Foster City, CA & Mechelen....
• [9] Financieele Dagblad (FD.nl) [de Lange, Rob]. (7/19/19). "News: Codename »Eagles«: the Making of Galapagos’ Unprecendeted Billion-Dollar Pact with Gilead"....
• [10] Galapagos N.V.. (7/14/19). "Press Release: Gilead and Galapagos Enter into Transformative Research and Development Collaboration". Foster City, CA & Mechelen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.